Overcoming the Limitations of Locally Administered Oncolytic Virotherapy

BMC Biomedical Engineering
doi 10.1186/s42490-019-0016-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Oncolytic Virotherapy

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Delivery and Biosafety of Oncolytic Virotherapy

Frontiers in Oncology
Cancer ResearchOncology
2020English

Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy

Cancer immunology research
Cancer ResearchImmunology
2018English

Targeting Pediatric Cancer Stem Cells With Oncolytic Virotherapy

Pediatric Research
Child HealthPediatricsPerinatology
2012English

Emerging Role of Natural Killer Cells in Oncolytic Virotherapy

ImmunoTargets and Therapy
AllergyImmunology
2015English

Oncolytic Virotherapy for Human Malignant Mesothelioma: Recent Advances

Oncolytic Virotherapy
2015English

Oncolytic Viruses: Overcoming Translational Challenges

Journal of Clinical Investigation
Medicine
2019English

Oncolytic Virotherapy as an Immunotherapeutic Strategy for Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2017English

Improved Oncolytic Virotherapy by Increasing Virus Spread Within Tumors.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy